The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg in restoring a normal luteal phase. The primary end-point will be the ongoing pregnancy rate. The secondary objectives will be the rate of endometrial biopsy showing an in phase endometrium after 3 months of treatment. The length of the luteal phase of the menstrual cycle after treatment will also be assessed and compared with the initial duration (from LH peak to onset of menstruation).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Progesterone will be administered subcutaneously once a day for 14 days/month, for 12 months.
A placebo solution will be administered subcutaneously once a day for 14 days/month, for 12 months.
Ongoing pregnancy rate at 12 weeks of gestation
Time frame: 12 weeks
Rate of in phase endometrial biopsies
Time frame: 3 months
Length of luteal phase
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.